<http://purl.uniprot.org/SHA-384/51A28D779A5EA5C8E5697F0DCE5FA047FA9F2496510C0F8957BC387FA8C02FF4AFEDDE7A657A13FAFCF314ED5C046FA9> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.uniprot.org/core/Patent_Citation> .
<http://purl.uniprot.org/SHA-384/51A28D779A5EA5C8E5697F0DCE5FA047FA9F2496510C0F8957BC387FA8C02FF4AFEDDE7A657A13FAFCF314ED5C046FA9> <http://www.w3.org/2004/02/skos/core#exactMatch> <http://purl.uniprot.org/patents/US5032514> .
<http://purl.uniprot.org/SHA-384/51A28D779A5EA5C8E5697F0DCE5FA047FA9F2496510C0F8957BC387FA8C02FF4AFEDDE7A657A13FAFCF314ED5C046FA9> <http://purl.uniprot.org/core/author> "Miller H.I." .
<http://purl.uniprot.org/SHA-384/51A28D779A5EA5C8E5697F0DCE5FA047FA9F2496510C0F8957BC387FA8C02FF4AFEDDE7A657A13FAFCF314ED5C046FA9> <http://purl.uniprot.org/core/author> "Lazarus R.A." .
<http://purl.uniprot.org/SHA-384/51A28D779A5EA5C8E5697F0DCE5FA047FA9F2496510C0F8957BC387FA8C02FF4AFEDDE7A657A13FAFCF314ED5C046FA9> <http://purl.uniprot.org/core/author> "Anderson S." .
<http://purl.uniprot.org/SHA-384/51A28D779A5EA5C8E5697F0DCE5FA047FA9F2496510C0F8957BC387FA8C02FF4AFEDDE7A657A13FAFCF314ED5C046FA9> <http://purl.uniprot.org/core/author> "Stafford R.K." .
<http://purl.uniprot.org/SHA-384/51A28D779A5EA5C8E5697F0DCE5FA047FA9F2496510C0F8957BC387FA8C02FF4AFEDDE7A657A13FAFCF314ED5C046FA9> <http://purl.uniprot.org/core/date> "1991-07-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.uniprot.org/SHA-384/51A28D779A5EA5C8E5697F0DCE5FA047FA9F2496510C0F8957BC387FA8C02FF4AFEDDE7A657A13FAFCF314ED5C046FA9> <http://purl.uniprot.org/core/title> "Metabolic pathway engineering to increase production of ascorbic acid intermediates." .